Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Radiopharm Theranostics Ltd banner
R

Radiopharm Theranostics Ltd
ASX:RAD

Watchlist Manager
Radiopharm Theranostics Ltd
ASX:RAD
Watchlist
Price on Oct 14: 0.005 AUD
Market Cap: AU$23.6m

Prices of ASX stocks are not being updated. The latest RAD price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.

Write Note Create Alert

Wall St Price Targets

RAD Price Forecast
No price targets yet

We don't have analyst price targets for RAD yet.

RAD Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for RAD yet.

Radiopharm Theranostics Ltd Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Continue RAD Research

Summary
RAD intrinsic value, competitors valuation, and company profile.
DCF Valuation
RAD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RAD stock valuation using valuation multiples.
Wall St Estimates
RAD price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RAD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Radiopharm Theranostics Ltd listings:
OTC • USD
RDPTF
 NASDAQ • USD
RADX
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RAD's stock price target?
Not Available

RAD does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Radiopharm Theranostics Ltd?
Projected CAGR
121%

The compound annual growth rate for Revenue over the next 7 years is 121%.

Back to Top
ALPHA SPREAD
Follow us
Join 363,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.